Delivery Order SPE2DB22D3301-SPE2DB24FZ3DR
Award Date
8/17/24
Potential Completion Date
8/19/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,094.83, is for the delivery of OGIVRI 420 MG VIALS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of OGIVRI 420 MG vials, with a potential value of $13,636.14 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery contract (IDC) that...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OGIVRI 420 MG vials. The contract, valued at $13,116.46, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite delivery contract (IDC) also awarded...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $13,514.50 for the supply of OGIVRI 420 MG VIALS. The contract has an ultimate completion date of June 14, 2024 and was awarded on June 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,324.97 firm fixed price contract is for the delivery of 4563372089 OGIVRI 420 MG vials. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp has...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of OGIVRI 420 MG vials, a pharmaceutical product, to the government. The $9,988.27 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2024 and is not designated as a set-aside. The award is likely part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,428.72, is a delivery order for OGIVRI 420 MG vials. It is a firm fixed-price contract with a completion date of January 2, 2025. The contract is not designated as a set-aside award. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,247,803 milligrams of the drug OGIVRI in 420 milligram vials. The $6,160.04 delivery order contract has a completion date of January 8, 2024 and was awarded on January 5, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is an experienced federal contractor, providing a range of pharmaceutical and medical...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY5AC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,740.10 Firm Fixed Price delivery order is for the supply of OGIVRI 420 MG vials, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Octagam 10% intravenous immunoglobulin (IVIG) vials. The contract has a ceiling value of $8,982.96 and a completion date of September 25, 2024. This award is not associated with a set-aside program. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range of...